Ada Health attracts a total of 120 million US dollars

The company intends to use the Series B financing to accelerate its own growth and become more active in the USA.

The Berlin-based digital health company Ada Health has announced the completion of its Series B financing round. Following an extension of 30 million US dollars, the company has now raised a total of 120 million US dollars in the round.

Ada Health intends to use the money to accelerate its growth and strengthen its presence in the USA. The company is experiencing strong demand in North America and has entered into partnerships with leading healthcare providers and systems. This is in addition to existing partnerships with companies such as Bayer, Novartis and Sutter Health. Ada Health also plans to develop new offerings to provide people with personalized health insights and empower them to actively manage their health.

The additional investments now made come from international investors Farallon Capital, Red River West and Bertelsmann Investments. Leaps by Bayer, the impact investment unit of Bayer AG, led the first part of the Series B financing round in May 2021. Over 90 million US dollars were raised at that time. Vitruvian Partners, Inteligo Bank, F4 and Mutschler Ventures also participated. Schroders Capital also acquired shares and became a shareholder.

Ada Health's technology combines artificial intelligence (AI) with a medical knowledge base. It is designed to help users better understand their symptoms and offers advice on appropriate healthcare. According to the company, the Ada app is the world's most popular and highest-rated symptom analysis app. Since its launch, Ada Health has performed over 26 million symptom analyses. The company also offers services for companies such as hospitals and health insurance companies.